LOPINAVIR/RITONAVIR RANBAXY 100MG/25 MG õhukese polümeerikattega tablett Estonja - Estonjan - Ravimiamet

lopinavir/ritonavir ranbaxy 100mg/25 mg õhukese polümeerikattega tablett

ranbaxy (u.k.) limited - lopinaviir+ritonaviir - õhukese polümeerikattega tablett - 100mg+25mg 60tk

PEMETREXED KOANAA infusioonilahuse kontsentraadi pulber Estonja - Estonjan - Ravimiamet

pemetrexed koanaa infusioonilahuse kontsentraadi pulber

koanaa healthcare gmbh - pemetrekseed - infusioonilahuse kontsentraadi pulber - 100mg 1tk

PEMETREXED ZENTIVA infusioonilahuse kontsentraadi pulber Estonja - Estonjan - Ravimiamet

pemetrexed zentiva infusioonilahuse kontsentraadi pulber

zentiva k.s. - pemetrekseed - infusioonilahuse kontsentraadi pulber - 500mg 1tk

PEMETREXED ZENTIVA K.S. infusioonilahuse kontsentraat Estonja - Estonjan - Ravimiamet

pemetrexed zentiva k.s. infusioonilahuse kontsentraat

zentiva k.s. - pemetrekseed - infusioonilahuse kontsentraat - 25mg 1ml 20ml 1tk; 25mg 1ml 4ml 1tk; 25mg 1ml 40ml 1tk

Pemetrexed Baxter Unjoni Ewropea - Estonjan - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastilised ained - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

PEMETREXED MYLAN PHARMA infusioonilahuse kontsentraadi pulber Estonja - Estonjan - Ravimiamet

pemetrexed mylan pharma infusioonilahuse kontsentraadi pulber

mylan s.a.s. - pemetrekseed - infusioonilahuse kontsentraadi pulber - 1000mg 1tk

PEMETREXED VIATRIS infusioonilahuse kontsentraat Estonja - Estonjan - Ravimiamet

pemetrexed viatris infusioonilahuse kontsentraat

viatris limited - pemetrekseed - infusioonilahuse kontsentraat - 25mg 1ml 40ml 1tk; 25mg 1ml 4ml 1tk; 25mg 1ml 20ml 1tk

PEMETREXED MYLAN PHARMA infusioonilahuse kontsentraadi pulber Estonja - Estonjan - Ravimiamet

pemetrexed mylan pharma infusioonilahuse kontsentraadi pulber

mylan s.a.s. - pemetrekseed - infusioonilahuse kontsentraadi pulber - 100mg 1tk

PEMETREXED TEVA infusioonilahuse kontsentraat Estonja - Estonjan - Ravimiamet

pemetrexed teva infusioonilahuse kontsentraat

teva b.v. - pemetrekseed - infusioonilahuse kontsentraat - 25mg 1ml 20ml 1tk; 25mg 1ml 40ml 1tk; 25mg 1ml 4ml 1tk

PEMETREXED TEVA infusioonilahuse kontsentraadi pulber Estonja - Estonjan - Ravimiamet

pemetrexed teva infusioonilahuse kontsentraadi pulber

teva b.v. - pemetrekseed - infusioonilahuse kontsentraadi pulber - 500mg 1tk